Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stephen Ellis
Icahn School of Medicine at Mount Sinai, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ontomics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Stephen Ellis (a Co-Investigator in this study) is a named co-inventor on a patent application related to CLIPMERGE, a medical decision-support software platform that collects, aggregates, and displays clinical data. The platform allows for personalized medical decision making. The CLIPMERGE tool has been utilized and also evaluated in the current study. The intellectual property related to the software has been licensed by the Icahn School of Medicine to Ontomics, a privately-held company in which Dr. Ellis is an equity holder. If the CLIPMERGE technology is commercially successful, Dr. Bottinger may benefit financially.
Genomic Medicine Pilot For Hypertension And Kidney Disease In Primary Care
We will conduct a randomized trial in a network of community health centers and primary care facilities to study the effects and challenges of incorporating genomic risk information in clinical care for patients of African ancestry with hypertension that are at risk for or have chronic kidney disease. The study will provide information whether patients at primary care facilities where genomic risk information for kidney disease is shared between providers and patients, and patients have different outcomes than patients in facilities where genomic risk information is not shared. This pilot project will create new insights on how genomic medicine approaches will be adopted and whether they can make a difference to improve primary care for hypertensive kidney disease in underserved minorities.
Filed on July 14, 2017.
Tell us what you know about Stephen Ellis's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Stephen Ellis”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stephen Ellis | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Ontomics | $0 - $4,999 |
| Stephen Ellis | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Ontomics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.